AnaptysBio Inc (ANAB)
22.30
+1.13
(+5.34%)
USD |
NASDAQ |
Nov 22, 15:33
AnaptysBio Total Assets (Quarterly): 493.42M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 493.42M |
| June 30, 2024 | 427.38M |
| March 31, 2024 | 405.84M |
| December 31, 2023 | 452.39M |
| September 30, 2023 | 487.33M |
| June 30, 2023 | 517.10M |
| March 31, 2023 | 551.79M |
| December 31, 2022 | 610.38M |
| September 30, 2022 | 618.50M |
| June 30, 2022 | 603.85M |
| March 31, 2022 | 625.17M |
| December 31, 2021 | 643.07M |
| September 30, 2021 | 424.34M |
| June 30, 2021 | 426.57M |
| March 31, 2021 | 396.42M |
| December 31, 2020 | 416.55M |
| September 30, 2020 | 384.75M |
| June 30, 2020 | 401.75M |
| March 31, 2020 | 424.23M |
| December 31, 2019 | 435.20M |
| Date | Value |
|---|---|
| September 30, 2019 | 451.50M |
| June 30, 2019 | 480.15M |
| March 31, 2019 | 494.23M |
| December 31, 2018 | 509.00M |
| September 30, 2018 | 523.12M |
| June 30, 2018 | 306.02M |
| March 31, 2018 | 314.84M |
| December 31, 2017 | 329.36M |
| September 30, 2017 | 121.94M |
| June 30, 2017 | 130.41M |
| March 31, 2017 | 131.11M |
| December 31, 2016 | 62.18M |
| September 30, 2016 | 55.84M |
| June 30, 2016 | 58.50M |
| March 31, 2016 | 54.72M |
| December 31, 2015 | 56.28M |
| September 30, 2015 | 60.88M |
| June 30, 2015 | 22.29M |
| December 31, 2014 | 25.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
384.75M
Minimum
Sep 2020
643.07M
Maximum
Dec 2021
487.30M
Average
443.79M
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Ligand Pharmaceuticals Inc | 954.87M |
| Agios Pharmaceuticals Inc | 1.792B |
| ADMA Biologics Inc | 390.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 409.05M |
| Shareholders Equity (Quarterly) | 84.37M |
| Current Ratio | 10.23 |